[May 27, 2015]

Research and Markets: Global Radiculopathy Clinical Trials Review, H1, 2015

Research and Markets (http://www.researchandmarkets.com/research/vmhnmq/radiculopathy) has announced the addition of the "Radiculopathy Global Clinical Trials Review, H1, 2015" report to their offering.

Radiculopathy Global Clinical Trials Review, H1, 2015" provides data on the Radiculopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Radiculopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treting Radiculopathy.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Top Companies Participating in Radiculopathy Therapeutics Clinical Trials

• Pfizer Inc.
• Biogen, Inc.
• Medtronic plc
• LifeNet Health Inc.
• Johnson & Johnson
• GlaxoSmithKline plc
• Evotec AG
• Convergence (News - Alert) Pharmaceuticals Ltd.
• Celgene Corporation

Clinical Trial Overview of Top Institutes / Government

• The Johns Hopkins University
• Shanghai University of Traditional Chinese Medicine
• Cairo University
• Department of Health, South Africa
• Emory University
• Henry Ford (News - Alert) Health System
• Horizon Health Network
• Karolinska Institute
• Kashani Social Security Hospital

For more information visit http://www.researchandmarkets.com/research/vmhnmq/radiculopathy

View source version on businesswire.com: http://www.businesswire.com/news/home/20150527005982/en/

[ Back To TMCnet.com's Homepage ]